Edwin Su
Orthopaedic Surgery · New York, NYNPI 1356459093
Payments from drug & device makers
What this record shows
This record is dominated by other: $12,143,303 of the $13,164,577 with a category attached, or 92.2%. Smith+Nephew accounts for 91.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $10,433,142 and has fallen 93.6% since, to $668,889 in 2025. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 207 payments — averaging $63,597 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$12.1M
- Encore Medical, LP$583K
- UOC USA Inc$306K
- Orthalign Inc$187K
- Zimmer Biomet$944
- Engage Uni, LLC$447
- plus $886 from 8 others
Across 87 payments — averaging $8250.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$718K
Across 11 payments — averaging $20,042 each. An ownership or investment interest held by the physician or an immediate family member.
- Overture Orthopaedics$120K
- Orthalign Inc$100K
- Insight Medical Systems, Inc.$0
- Engage Uni, LLC$0
What the payments were for
- Royalty or licence$715,2635%
- Consulting fees$144,9761%
- Speaking & faculty fees$104,3131%
- Travel & lodging$49,0860%
- Food & beverage$6,9500%
- Education$5540%
- Gifts$1140%
- Entertainment$190%
- Other$12,143,30392%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 68 | $12,086,266 |
| Encore Medical, LP | 1 | $583,055 |
| UOC USA Inc | 79 | $306,144 |
| Orthalign Inc | 40 | $186,836 |
| Zimmer Biomet | 6 | $944 |
| Engage Uni, LLC | 3 | $447 |
| Siemens Medical Solutions USA, Inc. | 2 | $217 |
| Medtronic | 1 | $178 |
| Exsomed Corporation | 2 | $174 |
| Medical Device Business Services, Inc. | 1 | $143 |
| Exactech, Inc. | 1 | $122 |
| Stryker | 1 | $19 |
| Overture Orthopaedics | 1 | $19 |
| Innovation Technologies Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Engage Partial Knee System$11,569,853
- OR3O Dual Mobility$324,368
- CONFORMITY$272,364
- ORTHALIGN PLUS$152,687
- R3 ACETABULAR$74,816
- Anthology$53,651
- Journey II$44,650
- OrthAlign Plus System$33,868
- REAL INTELLIGENCE$17,625
- U2, PSA, UTF, UTS, CONFORMITY, U-MOTION II, U-Star II$16,386
- REDAPT$13,600
- OXINIUM Hip$12,075
- CORI$12,075
- Birmingham Hip Resurfacing$11,611
- BIRMINGHAM HIP$9,375
- POLAR3$8,050
- Journey II BCS$7,933
- U-Motion II$7,810
- Journey II CR$7,763
- OR3O$6,613
How this compares
$13,164,577 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.
Other orthopaedic surgery in New York
- Anthony RomeoNew York$26.8M
- Lawrence LenkeNew York$26.8M
- William RicciNew York$11.6M
- Steven HaasNew York$11.3M
- Giles ScuderiNew York$10.7M
- Joseph ZuckermanNew York$9.9M
- Evan FlatowNew York$9.6M
- Bradford ParsonsNew York$9.4M
- Geoffrey WestrichNew York$7.1M
- Andrew PearleNew York$6.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.